HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Letizia Mattii Selected Research

Lipid Nanoparticles

3/2019Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Letizia Mattii Research Topics

Disease

4Heart Failure
04/2024 - 01/2012
3Neoplasms (Cancer)
05/2021 - 06/2008
2Cardiotoxicity
01/2022 - 05/2021
2Left Ventricular Dysfunction
01/2022 - 05/2015
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2019 - 01/2018
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
11/2012 - 01/2012
1Type 2 Diabetes Mellitus (MODY)
04/2024
1Hypothyroidism
09/2023
1Fibrosis (Cirrhosis)
01/2023
1Diabetic Cardiomyopathies
01/2023
1Hyperplasia
01/2022
1Cardiomyopathies (Cardiomyopathy)
05/2021
1Glioblastoma (Glioblastoma Multiforme)
03/2019
1Inflammation (Inflammations)
01/2019
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
01/2018
1Hyperglycemia
05/2015
1Ischemia
07/2014
1Myocardial Infarction
07/2014
1Infarction (Infarctions)
07/2014
1Obesity
01/2013
1Ganglion Cysts (Ganglion)
05/2009
1Goiter
05/2005
1IGA Glomerulonephritis (IGA Nephropathy)
01/2005

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2005
3Purinergic P1 Receptors (Adenosine Receptor)IBA
05/2015 - 01/2012
3Messenger RNA (mRNA)IBA
05/2015 - 01/2012
2Sodium-Glucose Transport ProteinsIBA
04/2024 - 01/2023
2Glucose (Dextrose)FDA LinkGeneric
04/2024 - 01/2022
2ConnexinsIBA
01/2023 - 05/2021
2ponatinibIBA
01/2022 - 05/2021
2Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2012
2Tyrosine Kinase InhibitorsIBA
05/2021 - 01/2019
2Connexin 43 (Connexin43)IBA
05/2021 - 05/2015
1Hypoglycemic Agents (Hypoglycemics)IBA
04/2024
1Thyroxine (Levothyroxine)FDA LinkGeneric
09/2023
13-iodothyronamineIBA
09/2023
1Streptozocin (Streptozotocin)FDA Link
01/2023
1empagliflozinIBA
01/2023
1Small Interfering RNA (siRNA)IBA
01/2022
1Insulin (Novolin)FDA Link
01/2022
1Connexin 26IBA
05/2021
1Lipid NanoparticlesIBA
03/2019
1nutlin 3IBA
03/2019
1Interleukin-6 (Interleukin 6)IBA
05/2015
1Adenosine (Adenocard)FDA LinkGeneric
07/2014
1Purine NucleosidesIBA
07/2014
1Natriuretic PeptidesIBA
01/2013
1AdiponectinIBA
11/2012
1AMP-Activated Protein KinasesIBA
11/2012
1ParaffinIBA
05/2009
1src-Family KinasesIBA
06/2008
1historphinIBA
06/2008
1Low Density Lipoprotein Receptor-Related Protein-2IBA
05/2005
1Thyroid HormonesIBA
05/2005
1AntigensIBA
01/2005
1Fibronectins (Fibronectin)IBA
01/2005
1Transforming Growth Factor beta1 (TGF beta 1)IBA
01/2005

Therapy/Procedure

1Glycemic Control
04/2024
1Intraperitoneal Injections
01/2023
1Therapeutics
05/2015